NASDAQ: PHAR
Pharming Group Nv Stock Ownership - Who owns Pharming Group Nv?

Insider buying vs selling

Have Pharming Group Nv insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PHAR insiders and whales buy or sell their stock.

PHAR Shareholders

What type of owners hold Pharming Group Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Silverberg Bernstein Capital Management LLC0.01%50,547$899.74kInstitution
Newedge Advisors LLC0.00%28,868$513.85kInstitution
Millennium Management LLC0.00%20,385$362.85kInstitution
Citadel Advisors LLC0.00%17,690$314.88kInstitution
Smartharvest Portfolios LLC0.00%12,687$225.83kInstitution
Morgan Stanley0.00%7,700$137.06kInstitution
Eversource Wealth Advisors LLC0.00%904$16.09kInstitution
Nalls Sherbakoff Group LLC0.00%870$15.49kInstitution
Bnp Paribas Financial Markets0.00%800$14.24kInstitution
Bessemer Group Inc0.00%3$53.40Institution

1 of 2

PHAR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHAR0.02%0.00%
DBVT5.46%11.37%Net SellingNet Selling
CRVS55.58%38.94%Net BuyingNet Buying
INBX75.74%24.26%Net Selling
EYPT29.17%70.83%Net SellingNet Buying

Pharming Group Nv Stock Ownership FAQ

Who owns Pharming Group Nv?

Pharming Group Nv (NASDAQ: PHAR) is owned by 0.02% institutional shareholders, 0.00% Pharming Group Nv insiders, and 99.98% retail investors. Silverberg Bernstein Capital Management LLC is the largest individual Pharming Group Nv shareholder, owning 50,547.00 shares representing 0.01% of the company. Silverberg Bernstein Capital Management LLC's Pharming Group Nv shares are currently valued at $899.74k.

If you're new to stock investing, here's how to buy Pharming Group Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.